논문 상세보기

Production and Breeding of Transgenic Cloned Pigs Expressing Human CD73 KCI 등재

  • 언어ENG
  • URLhttps://db.koreascholar.com/Article/Detail/329790
서비스가 종료되어 열람이 제한될 수 있습니다.
Development & Reproduction (발생과 생식)
한국발생생물학회 (The Korea Society Of Developmental Biology)
초록

One of the reasons to causing blood coagulation in the tissue of xenografted organs was known to incompatibility of the blood coagulation and anti-coagulation regulatory system between TG pigs and primates. Thus, overexpression of human CD73 (hCD73) in the pig endothelial cells is considered as a method to reduce coagulopathy after pig-to-non-humanprimate xenotransplantation. This study was performed to produce and breed transgenic pigs expressing hCD73 for the studies immune rejection responses and could provide a successful application of xenotransplantation. The transgenic cells were constructed an hCD73 expression vector under control porcine Icam2 promoter (pIcam2-hCD73) and established donor cell lines expressing hCD73. The numbers of transferred reconstructed embryos were 127 ± 18.9. The pregnancy and delivery rate of surrogates were 8/18 (44%) and 3/18 (16%). The total number of delivered cloned pigs were 10 (2 alive, 7 mummy, and 1 died after birth). Among them, three live hCD73-pigs were successfully delivered by Caesarean section, but one was dead after birth. The two hCD73 TG cloned pigs had normal reproductive ability. They mated with wild type (WT) MGH (Massachusetts General Hospital) female sows and produced totally 16 piglets. Among them, 5 piglets were identified as hCD73 TG pigs. In conclusion, we successfully generated the hCD73 transgenic cloned pigs and produced their litters by natural mating. It can be possible to use a mate for the production of multiple transgenic pigs such as α-1,3-galactosyltransferase knock-out /hCD46 for xenotransplantation.

저자
  • Seung-Chan Lee(Animal Biotechnology Division, National Institute of Animal Science, RDA)
  • Haesun Lee(Animal Biotechnology Division, National Institute of Animal Science, RDA)
  • Keon Bong Oh(Animal Biotechnology Division, National Institute of Animal Science, RDA)
  • In-Sul Hwang(Animal Biotechnology Division, National Institute of Animal Science, RDA)
  • Hyeon Yang(Animal Biotechnology Division, National Institute of Animal Science, RDA)
  • Mi-Ryung Park(Animal Biotechnology Division, National Institute of Animal Science, RDA)
  • Sun-A Ock,(Animal Biotechnology Division, National Institute of Animal Science, RDA)
  • Jae-Seok Woo(Animal Biotechnology Division, National Institute of Animal Science, RDA)
  • Gi-Sun Im(Animal Biotechnology Division, National Institute of Animal Science, RDA)
  • Seongsoo Hwang(Animal Biotechnology Division, National Institute of Animal Science, RDA) Corresponding Author